鹏华中证中药ETF联接C(016892)申购赎回 |
|
|
| 报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
| 2025/12/31 |
372,783,000 |
411,950,000 |
656,799,000 |
617,631,000 |
39,168,000 |
10.51% |
| 2025/9/30 |
259,262,000 |
372,783,000 |
636,328,000 |
522,806,000 |
113,522,000 |
43.79% |
| 2025/6/30 |
124,714,000 |
259,262,000 |
692,558,000 |
558,010,000 |
134,548,000 |
107.89% |
| 2025/6/30 |
223,390,000 |
259,262,000 |
421,818,000 |
385,946,000 |
35,872,000 |
16.06% |
| 2025/3/31 |
124,714,000 |
223,390,000 |
270,740,000 |
172,065,000 |
98,675,000 |
79.12% |
| 2024/12/31 |
92,906,500 |
124,714,000 |
657,421,000 |
625,613,000 |
31,808,000 |
34.24% |
| 2024/12/31 |
170,642,000 |
124,714,000 |
202,484,000 |
248,413,000 |
-45,929,000 |
-26.92% |
| 2024/9/30 |
120,684,000 |
170,642,000 |
209,515,000 |
159,557,000 |
49,958,000 |
41.4% |
| 2024/6/30 |
92,906,500 |
120,684,000 |
245,421,000 |
217,643,000 |
27,778,000 |
29.9% |
| 2024/6/30 |
101,431,000 |
120,684,000 |
147,982,000 |
128,729,000 |
19,253,000 |
18.98% |
| 2024/3/31 |
92,906,500 |
101,431,000 |
97,439,000 |
88,914,700 |
8,524,300 |
9.18% |
| 2023/12/31 |
96,432,900 |
92,906,500 |
721,401,000 |
724,928,000 |
-3,527,000 |
-3.66% |
| 2023/12/31 |
108,096,000 |
92,906,500 |
97,132,400 |
112,322,000 |
-15,189,600 |
-14.05% |
| 2023/9/30 |
119,396,000 |
108,096,000 |
173,214,000 |
184,514,000 |
-11,300,000 |
-9.46% |
| 2023/6/30 |
96,432,900 |
119,396,000 |
451,055,000 |
428,091,000 |
22,964,000 |
23.81% |
| 2023/6/30 |
102,547,000 |
119,396,000 |
255,952,000 |
239,102,000 |
16,850,000 |
16.43% |
| 2023/3/31 |
96,432,900 |
102,547,000 |
195,103,000 |
188,989,000 |
6,114,000 |
6.34% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。
